pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 607 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    TRK-950
    Adenocarcinoma Of The Gastroesophageal Junction Toray Industries Inc
  • Phase 2
    TSC-100
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$TCRX TScan Therapeutics, Inc.
  • Phase 2
    TSC-101
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$TCRX TScan Therapeutics, Inc.
  • Phase 2
← prev
page 11 of 21
next →
131
Pain89
Neurology1
TSN-1611
Solid Tumor
Tyligand Biotechnology (Shanghai) Co Ltd
  • Phase 2
    TST-003
    Metastatic Colorectal Cancer Transcenta Holding Ltd
  • Phase 2
    TTI-101
    Metastatic Hepatocellular Carcinoma (HCC)$TVRD Tvardi Therapeutics, Inc.
  • Phase 2
    TTXMC-138
    Solid Tumor$RNAZ Transcode Therapeutics, Inc.
  • Phase 2
    TUB-040
    Non-Small Cell Lung Cancer Tubulis GmbH
  • Phase 2
    TVI-Kidney-1
    Renal Cell Carcinoma TVAX Biomedical Inc
  • Phase 2
    Temferon
    Glioblastoma Multiforme (GBM) Genenta Science SpA
  • Phase 2
    UB-941
    Colon Cancer UBI Pharma Inc
  • Phase 2
    VBC-103
    Metastatic Transitional (Urothelial) Tract Cancer Avenzo Therapeutics Inc
  • Phase 2
    VBI-1901
    Recurrent Glioblastoma Multiforme (GBM) VBI Vaccines Inc
  • Phase 2
    VG-161
    Bile Duct Cancer (Cholangiocarcinoma) Virogin Biotech Ltd
  • Phase 2
    VLS-1488
    Ovarian Cancer Volastra Therapeutics Inc
  • Phase 2
    VMT-01
    Metastatic Melanoma$CATX Perspective Therapeutics, Inc.
  • Phase 2
    VMT-a-NET
    Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)$CATX Perspective Therapeutics, Inc.
  • Phase 2
    VNX-101
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla… Vironexis Biotherapeutics Inc
  • Phase 2
    VNX-202
    Gastric Cancer Vironexis Biotherapeutics Inc
  • Phase 2
    VT-3989
    Malignant Pleural Mesothelioma Vivace Therapeutics Inc
  • Phase 2
    VXM-01
    Recurrent Glioblastoma Multiforme (GBM) Vaximm AG
  • Phase 2
    WP-1066
    Glioblastoma Multiforme (GBM)$MBRX Moleculin Biotech, Inc.
  • Phase 2
    WSD-0922
    Non-Small Cell Lung Cancer Wayshine Biopharma Inc
  • Phase 2
    WTX-330
    Colorectal Cancer$HOWL Werewolf Therapeutics, Inc.
  • Phase 2
    XmAb bispecific antibody
    Unspecified Cancer$NVS NOVARTIS AG
  • Phase 2
    YH-42946
    Non-Small Cell Lung Cancer Yuhan Corp
  • Phase 2
    YL-13027
    Solid Tumor Shanghai Yingli Pharmaceutical Co Ltd
  • Phase 2
    YL-15293
    Colorectal Cancer Shanghai Yingli Pharmaceutical Co Ltd
  • Phase 2
    ZEN-3694
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Zenith Epigenetics Ltd
  • Phase 2
    abefolastat tesaroxetan
    abefolastat tesaroxetan
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Clarity Pharmaceuticals Ltd